Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway
ConclusionTherapy with medications targeting the prostacyclin pathway is a potential risk factor for the development of symptomatic thyroid disease.
Source: Lung - Category: Respiratory Medicine Source Type: research
More News: Autoimmune Disease | Databases & Libraries | Hypertension | Hyperthyroidism | Respiratory Medicine | Thyroid